thrombolytic therapy

(redirected from Thrombolytic drug)
Also found in: Thesaurus, Medical, Encyclopedia, Wikipedia.
Related to Thrombolytic drug: Anticoagulant drug
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.thrombolytic therapy - therapy consisting of the administration of a pharmacological agent to cause thrombolysis of an abnormal blood clot
therapy - (medicine) the act of caring for someone (as by medication or remedial training etc.); "the quarterback is undergoing treatment for a knee injury"; "he tried every treatment the doctors suggested"; "heat therapy gave the best relief"
Based on WordNet 3.0, Farlex clipart collection. © 2003-2012 Princeton University, Farlex Inc.
Mentioned in ?
References in periodicals archive ?
Although Urokinase is a thrombolytic drug of the first generation, it is widely used in China.
Currently it has two; (1) Kinlytic urokinase, a biologic thrombolytic drug (used to dissolve blood clots) and (2) LumiSort cell-sorting, a technology for ultra-rapid and efficient sorting that can be used to enrich cell populations of interest.
Epigrammatic Record of Thrombolytic Drug. Perhaps the field of fibrinolysis originated with Morgagni in 1761 [19].
Microspheres, in combination with ultrasound can lyse thrombi even without a thrombolytic drug [52].
The thrombolytic drug is another important factor in the treatment of DVT.
Also the catheter-directed thrombolyses could be preferred because of possibly fewer haemorrhagic events and a higher concentration of the thrombolytic drug at the site of clots (Marti et al 2014; Wang et al 2015).
(3) The principal advantage of intra-arterial thrombolysis is the direct delivery of a highly concentrated thrombolytic drug in the vicinity of the thrombus with a lesser systemic distribution of the drug, while mechanical thrombectomy has the advantage of quick restoration of cerebral blood flow by clot extraction or clot fragmentation.
The drug should not be used in patients who have been recently treated with a platelet inhibitor, a thrombolytic drug, or in those who have undergone full anticoagulation with warfarin.
SAN ANTONIO - When intravenous thrombolysis fails to dissolve a brain clot, intraarterial delivery of the thrombolytic drug might do the trick.
Streptokinase is not widely used as a thrombolytic drug in the United States.
That's because this new trial, conducted in India, China, Pakistan, and several South American countries and involving 15,570 patients, included only about 100 patients treated with a fibrin-specific thrombolytic drug. Close to 80% of the patients received acute treatment to clear their coronary thrombus, but this treatment was primarily streptokinase, in about 50% of patients, urokinase, in about 23% of patients, and primary PCI, in about 6% of patients.